The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.
about
Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibilityAssociations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosusSurvival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish communitySerum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosusGenetic Factors in Systemic Lupus Erythematosus: Contribution to Disease PhenotypeRelevant concepts of functioning for patients with systemic lupus erythematosus identified in a Delphi exercise of experts and a literature reviewSynergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosusFactors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception CohortVoice disorder in systemic lupus erythematosus.The impact of rural residency on the expression and outcome of systemic lupus erythematosus: data from a multiethnic Latin American cohort.Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Libman-Sacks endocarditis and embolic cerebrovascular disease.Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres.Standard medical care of patients with systemic lupus erythematosus (SLE) in large specialised centres: data from the Russian Federation, Ukraine and Republic of Kazakhstan (ESSENCE).Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII).Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosusClinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients.Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.Factors associated with coronary artery calcification in young female patients with SLE.Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients.The relationship between initial clinical manifestation and long-term prognosis of patients with systemic lupus erythematosus.Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired.Discordant assessment of lupus activity between patients and their physicians: the Singapore experience.Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.Evaluation of clinical outcomes and renal vascular pathology among patients with lupus.Chronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus.The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups.Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.
P2860
Q21195675-491803B3-7F2E-42A7-954B-340FA1C6B289Q22299246-593F20E7-EC89-410D-AC10-03A28F9F7827Q22299249-20543F66-3668-4859-8CB9-DA4637807B46Q24793357-487FA2BC-4C82-4936-AB15-78B5E42CC0A8Q26769670-6A29F0C3-5941-4B01-900B-BCECD9E59A56Q27014980-03219770-8519-44A1-B276-0D212ED2285EQ28140756-2B62B945-D7DB-4338-AFE9-466CFB7C473EQ28608340-8517E1FF-DBE9-46D4-BE75-6A533DF63A37Q30357218-538BFD94-0864-43CE-B950-4EA09B482642Q30560762-48607D1C-684E-44C7-A0F5-FCD9F8638C8DQ30560952-E6C3C9EB-89F6-4315-A19C-899E80C6B4F1Q30573314-B2EA1BF8-10F0-419C-A6B4-7F3E7D742386Q30645037-5FB0AF67-DD4B-469B-AE0B-32C2C29487A2Q30756915-9540B00F-8547-4615-BD63-1E29954C1DCEQ30778909-72D95281-9DB1-4B7A-8759-9AFF8EDB5599Q30791606-B3C85AB4-1770-4DCA-882E-C5A339E212EFQ30886868-2C441E41-B97E-4D0F-A19E-0B6638E162A7Q30900345-4A343FB0-CEC5-4A0B-A73A-81B6308D3AB5Q30993000-1FA596EE-6FBC-4E3E-B813-9BCD0C2B7C96Q31050711-FFE9C7EC-D5DE-401C-8B0C-2160B6156A74Q31102783-D8985706-0489-4F0D-816B-75CAA59E4952Q31121775-EBA6C5B2-630C-4DBC-AA2B-F31FED93620BQ31122937-E51B83EB-1F67-436F-8B32-0AE7C54A1F2BQ31145482-30C204C1-F5BC-4722-BBD8-8E9A5DF08EE1Q32175831-56414A25-6949-46AB-B799-1315E4A39F52Q33188178-5A3DF147-5571-4AEF-ABE4-A7F5D67364B6Q33341018-F21426F2-E3B5-4079-9D1C-651D68EC7C14Q33359257-D28F0E5F-36D2-44D5-A0BB-386F3DC27E5CQ33372908-C8CC6741-A222-438B-BE75-7C86CA16D76EQ33374004-834027FE-B21E-48DF-8D6A-8B2CD70BC3F4Q33375575-FEA8D8B3-8F55-4A28-9F2D-BD54F016A6C4Q33386907-E0D281B9-1B4B-4DC0-99E4-AA3F57FACC0FQ33387473-A8F24D0B-0912-457D-BD61-BFFB3D8D13D1Q33400371-1D107117-528D-40C2-A11F-F473FB66CCD6Q33425025-4BEEF8AF-781D-4231-998F-B221362BCD3DQ33425674-75A6ADAD-212D-474E-A06F-4AE4564C7AB3Q33425745-368BB492-6136-48DE-8AA5-A846010567F7Q33438808-BBEDAD29-7FB0-4995-BC1A-340F5BA56C71Q33448450-2C46BAC1-97C4-4928-A08C-447BF0FC2536Q33455990-74C53491-78B0-4A14-BDA8-7861FF469885
P2860
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The development and initial va ...... systemic lupus erythematosus.
@en
type
label
The development and initial va ...... systemic lupus erythematosus.
@en
prefLabel
The development and initial va ...... systemic lupus erythematosus.
@en
P2093
P50
P356
P1476
The development and initial va ...... systemic lupus erythematosus.
@en
P2093
Goldsmith C
Kalunian K
Maddison P
P304
P356
10.1002/ART.1780390303
P577
1996-03-01T00:00:00Z